FDA Officially Ranks Condoms for Anal and Vaginal Use as 'Class II' Gadgets
Published Date: 5/8/2026
Rule
Summary
The FDA is officially classifying external condoms for anal or vaginal sex as Class II devices, meaning they have special safety rules but aren’t super strict. This change helps make sure condoms are safe and effective while making it easier for new, innovative products to reach you. The new rules took effect on May 8, 2026, and could speed up how quickly better condoms hit the market without extra costs.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Condoms Reclassified to Class II
The FDA has officially classified external condoms for anal or vaginal intercourse as Class II (special controls). FDA says this classification provides a reasonable assurance of safety and effectiveness and will enhance patient access to innovative condom products by reducing regulatory burdens; the order is effective May 8, 2026 (classification applicable February 23, 2022).
New Testing and Labeling Rules for Makers
Manufacturers must meet new special controls: clinical acute failure modes studies for total and individual failure rates; non‑clinical performance testing including mechanical/material integrity and (for non‑latex materials) viral penetration testing; biocompatibility evaluation; shelf‑life performance and package integrity data; and specific labeling elements. These controls are codified at 21 CFR 884.5305 and apply to devices classified as external condoms for anal or vaginal intercourse.
Premarket 510(k) Notification Required
FDA states that external condoms for anal or vaginal intercourse are subject to premarket notification under section 510(k) of the FD&C Act and that it has not determined these devices should be exempt under section 510(m). Sponsors must therefore submit a 510(k) to market these devices unless FDA later exempts them.
Labels Must Give Clear Safety & Effectiveness Info
Required labeling must include (if indicated for vaginal intercourse) a contraceptive effectiveness table comparing typical and perfect use pregnancy rates; statements on lubricant compatibility; statements of adverse events (including infection, pregnancy, tissue reaction, mechanical injury, improper use); an expiration date; STI protection specifics; a statement that risks are not eliminated; a warning about failure during anal intercourse if adequate lubricant is not used; a warning that the device is single‑use; and a precaution about allergy risk.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20727, Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
The FDA is officially classifying home test kits that detect non-viral germs causing sexually transmitted infections as Class II devices, meaning they have special safety rules but fewer hurdles than the strictest category. This change, effective October 9, 2026, helps make these tests safer and easier to get, benefiting patients and innovators alike. If you make or use these home test kits, this update means better access and clear safety standards without extra costs or delays.
Previous / Next Documents
Previous: 2026-09148, Implementation of the Administrative False Claims Act; Correction
The Federal Labor Relations Authority fixed a few wording mistakes in its new rules for the Administrative False Claims Act, which helps catch and stop false claims against the government. These corrections make the rules clearer and officially take effect on May 26, 2026. If you work with government claims or legal procedures, these updates keep things running smoothly without changing any costs or deadlines.
Next: 2026-09155, Changes to National Firearms Act Tax Remittance Provisions
Starting June 10, 2026, the ATF is updating its rules to match new laws that lower the tax rates on certain National Firearms Act (NFA) guns. This means folks who deal with these firearms will pay less tax when registering or transferring them. The changes keep the rules clear, fair, and up-to-date with the latest law.